Bajamunde, Reyvin .
HRN: 25-30-79 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/19/2024
CEFUROXIME 750MG (VIAL)
06/19/2024
06/19/2024
IV
750mg
Q8
UTI
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Urinary TractProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes